Recruiting Lymphoma Studies in Austin
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
This is a Phase 1b/2, multicenter, open-label, study of JNJ-90014496, an autologous bi-specific chimeric antigen receptor (CAR) T-cell therapy targeting both cluster of differentiation (CD) CD19 and C...
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
First-in-human, open-label, dose-finding and dose-expansion study of UCART20x22 administered intravenously in subjects with relapsed or refractory B-Cell Non-Hodgkin Lymphoma (B-NHL). The purpose of t...
About Lymphoma Clinical Trials in Austin
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Austin, TEXAS. These studies are seeking a combined 465 participants. Research is being sponsored by Janssen Research & Development, LLC, Cellectis S.A.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Austin — FAQ
Are there lymphoma clinical trials in Austin?
Yes, there are 2 lymphoma clinical trials currently recruiting in Austin, TEXAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Austin?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.
Are clinical trials in Austin free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov